Topiramate oral liquid suspension patent granted
ChangeBridge: Patent Grants - Therapeutics (A61P)
Summary
USPTO granted patent US12594241B2 to inventors Paul Sudhakar and Scott Boyer for an oral liquid suspension formulation containing topiramate (Application No. 18462651). The patent contains 29 claims covering the composition and methods of medical treatment using the formulation. Generic and branded pharmaceutical manufacturers should assess this patent for potential freedom-to-operate implications.
What changed
The USPTO granted patent US12594241B2 for a topiramate oral liquid suspension composition and methods of treatment. Inventors Paul Sudhakar and Scott Boyer filed the application on September 7, 2023 (Application No. 18462651), which has now matured into a granted patent containing 29 claims.
Pharmaceutical companies developing generic or branded topiramate formulations should review the patent claims to assess potential infringement risks and freedom-to-operate. Competitors seeking to commercialize similar oral liquid suspensions will need to either design around the claims or pursue licensing arrangements with the patent holder.
What to do next
- Review patent claims for freedom-to-operate assessment on competing topiramate formulations
- Consider designing around patent claims if developing generic oral liquid suspensions
- Consult IP counsel if developing products that may fall within the 29 claims
Source document (simplified)
Topiramate oral liquid suspension and use thereof
Grant US12594241B2 Kind: B2 Apr 07, 2026
Inventors
Paul Sudhakar, Scott Boyer
Abstract
Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
CPC Classifications
A61K 47/02 A61K 47/26 A61K 31/7048 A61K 47/12 A61K 9/0095 A61K 31/36 A61K 47/38 A61K 9/0056 A61K 47/14 A61K 47/10 A61K 9/10 A61K 47/36 A61P 1/00 Y02A 50/30
Filing Date
2023-09-07
Application No.
18462651
Claims
29
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Therapeutics (A61P) publishes new changes.